Shots:
The study evaluated the levels of GFAP & UCH-L1 present in blood plasma within 24hrs of injury using the i-STAT TBI Plasma Test in patients (n=1696) with TBI vs GOSE analysis of biomarker levels in patients after 6mos.
The results demonstrated that the high levels of biomarkers, GFAP & UCH-L1 correlate with death/severe injury. Additionally, the prediction rate of day-of-injury blood test on the same timepoint was found to be 86% for both GFAP & UCH-L1 vs 87% for GFAP & 89% for UCH-L1 @6mos.
Abbott & the US DoD jointly developed the TBI blood test whereas Abbott expects to receive the FDA clearance under BTD for the TBI test on its Alinity I (CE marked) & ARCHITECT core laboratory instruments
Ref: PR Newswire | Image: Abbott
